BSE filing, NSE: SKFINDIA. Summary written from the filing by ALFA Finder's alert engine.
SKF India Ltd: key numbers
- Share price
- ₹1,423.00
- Market cap
- ₹7,035 Cr
- Revenue (annual)
- ₹3,763 Cr
- Net profit (annual)
- ₹265.9 Cr
- P/E (TTM)
- 33.6×Sector 52.2×
- Promoter holding
- 52.58%+0.00% QoQ
- FII holding
- 7.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SKF India Ltd
All →SKF India Other Announcement
SKF India Ltd has filed its quarterly shareholding pattern under Regulation 31, detailing the distribution of equity shares among promoters and public shareholders.
SKF India Investor Presentation: Key Takeaways
SKF India reported FY 2025-26 revenue of INR 21,295 Mn with a 15% EBITDA margin following the demerger of its Industrial business into a separate entity.
SKF India Annual General Meeting
SKF India concluded its 65th Annual General Meeting on August 14, 2026. Shareholders approved all agenda items, including the final dividend declaration.
SKF India Results Update
SKF India reported Q1 FY26 revenue of ₹5,877.9 Million. The company observed 27.1% year-on-year growth in revenue and 0.1% growth in EBITDA.
- Value
- ₹587.8 Cr
SKF India Q1 FY27 Results: Net Profit ₹61.9 Cr, Down 47.6% YoY
SKF India Ltd reported revenue from operations of ₹587.8 Cr (-54.2% YoY) and net profit of ₹61.9 Cr (-47.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹61.9 Cr · -47.6% YoY
SKF India Board Meeting Date
SKF India Limited has scheduled a board meeting on 12th August 2026 to consider and approve its unaudited financial results for the quarter ended 30th June 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.